This inventor holds 5 USPTO granted patents. Top assignee: Amderma Pharmaceuticals, LLC. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2020
Title: Innovations of Annadurai Marimuthu Senthilkumar
Introduction
Annadurai Marimuthu Senthilkumar is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for the preparation of specific chemical compounds. With a total of five patents to his name, his work has the potential to impact treatments for various skin conditions.
Latest Patents
Senthilkumar's latest patents focus on the processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts. These patents detail methods for creating a crystalline form of potassium 2,5-dihydroxybenzenesulfonic acid. Additionally, they provide methods for treating psoriasis and rosacea by administering these crystalline forms, showcasing his commitment to advancing therapeutic options in dermatology.
Career Highlights
He is currently associated with Amderma Pharmaceuticals, LLC, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong emphasis on practical applications that can lead to improved patient outcomes.
Collaborations
Senthilkumar collaborates with talented professionals in his field, including Unni Santhosh and Bodireddy Mohan Reddy. These collaborations enhance the research and development efforts at Amderma Pharmaceuticals, fostering a creative environment for innovation.
Conclusion
Annadurai Marimuthu Senthilkumar's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve the quality of life for many individuals suffering from skin conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile